Kazia Therapeutics Limited
KZIA
$13.25
$3.1931.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.76% | -14.84% | -79.86% | -51.58% | -27.77% |
| Total Depreciation and Amortization | -49.64% | -24.77% | -0.75% | -0.96% | -2.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.58% | 329.53% | 516.38% | 569.97% | 674.39% |
| Change in Net Operating Assets | -129.42% | -59.27% | 193.72% | 153.22% | 125.73% |
| Cash from Operations | -37.75% | -11.35% | 8.63% | 24.17% | 38.46% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.04% | -100.08% | -0.15% | -- |
| Total Debt Repaid | -- | 100.11% | 100.22% | 0.43% | -- |
| Issuance of Common Stock | 129.33% | 36.04% | -9.54% | -33.56% | -55.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 716.41% | 306.30% | 92.27% | 61.48% | 6.04% |
| Cash from Financing | 165.42% | 49.45% | -8.45% | -32.19% | -55.18% |
| Foreign Exchange rate Adjustments | -192.77% | 6,888.89% | 1,473.40% | 307.06% | -80.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.10% | 148.90% | 37.79% | -39.76% | -65.82% |